Herriot Tabuteau
2017
In 2017, Herriot Tabuteau earned a total compensation of $1.1M as Chief Executive Officer and Chairman of the Board at Axsome Therapeutics, a 67% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,100 |
|---|---|
| Option Awards | $488,252 |
| Salary | $435,000 |
| Total | $1,123,352 |
Tabuteau received $488.3K in option awards, accounting for 43% of the total pay in 2017.
Tabuteau also received $200.1K in non-equity incentive plan and $435K in salary.
Rankings
In 2017, Herriot Tabuteau's compensation ranked 8,419th out of 14,666 executives tracked by ExecPay. In other words, Tabuteau earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,419 out of 14,666 | 43rd |
Division Manufacturing | 3,193 out of 5,772 | 45th |
Major group Chemicals And Allied Products | 1,060 out of 2,075 | 49th |
Industry group Drugs | 836 out of 1,731 | 52nd |
Industry Pharmaceutical Preparations | 655 out of 1,333 | 51st |
Source: SEC filing on April 27, 2018.
Tabuteau's colleagues
We found two more compensation records of executives who worked with Herriot Tabuteau at Axsome Therapeutics in 2017.